High Court Refuses Ranbaxy's Lipitor Appeal
The U.S. Supreme Court refused Monday to intervene in Ranbaxy Laboratories Ltd.'s appeal of an appeals court ruling that upheld a Pfizer Inc. patent for the cholesterol-lowering drug Lipitor, the world's...To view the full article, register now.
Already a subscriber? Click here to view full article